Inflamalps
Valais, CH · 1 known investors
Inflamalps is a biopharmaceutical company discovering anti-inflammatory and anti-microbial molecules, with its lead candidate INF101 targeting dry eye disease in ophthalmology. Since 2020 it has run a drug discovery program for novel anti-microbial molecules in partnership with academic and CRO partners across Europe and New Zealand.
Investors · 1
Frequently asked questions
- What does Inflamalps do?
- Inflamalps is a biopharmaceutical company discovering anti-inflammatory and anti-microbial molecules, with its lead candidate INF101 targeting dry eye disease in ophthalmology. Since 2020 it has run a drug discovery program for novel anti-microbial molecules in partnership with academic and CRO partners across Europe and New Zealand.
- Who are Inflamalps's investors?
- Inflamalps's investors include Waarde Capital.
- Where is Inflamalps headquartered?
- Inflamalps is headquartered in Valais, CH.